Corrigendum To: Establishment of a High Content Image Platform to Measure NF-κB Nuclear Translocation in LPS-induced RAW264.7 Macrophages for Screening Anti-inflammatory Drug Candidates.

IF 2.1 4区医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

Current drug metabolism Pub Date : 2025-01-01 DOI:10.2174/138920022508250116114158

Yan-Yu Zhang, Yun-Da Yao, Qi-Qing Cheng, Yu-Feng Huang, Hua Zhou

引用次数: 0

Abstract

In the article titled "Establishment of a High Content Image Platform to Measure NF-κB Nuclear Translocation in LPSinduced RAW264.7 Macrophages for Screening Anti-inflammatory Drug Candidates" published in Current Drug Metabolism, Volume 23, No. 5, 2022, pp. 394-414 [1], the authors have identified error in Fig. (8C). They request correction to this figure to ensure accuracy in the representation of their findings. We regret the error and apologize to readers. The original article can be found online at: https://www.eurekaselect.com/article/122464.

查看原文本刊更多论文

建立高含量图像平台，测量lps诱导的RAW264.7巨噬细胞中NF-κB核易位，筛选抗炎候选药物。

在发表于《Current Drug Metabolism》，vol . 23, No. 5, 2022, pp. 394- 414[1]》的文章“建立一个高含量的图像平台来测量NF-κB核易位在lp诱导的RAW264.7巨噬细胞中用于筛选抗炎候选药物”中，作者发现了图（8C）中的错误。他们要求对这一数字作出更正，以确保其调查结果的表述准确。我们对这个错误感到遗憾，并向读者道歉。原文可在https://www.eurekaselect.com/article/122464网站上找到。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current drug metabolism 医学-生化与分子生物学

CiteScore

4.30

自引率

4.30%

发文量

审稿时长

4-8 weeks

期刊介绍： Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism. More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.